Citations

Clear

83 citation(s) found for "Shen, Win".

Impact of pulsed electromagnetic field therapy on vascular function and blood pressure in hypertensive individuals
Stewart, Glenn M. , Wheatley, Courtney M. , Johnson, Bruce D. , Shen, Win K., Kim, Chul‐Ho , Wheatley-Guy, Courtney M

Mayo Clinic

The Journal of Clinical Hypertension | May 13, 2020 | Volume: 22 | Issue: 6 | Pages: 1083-1089

10.1111/jch.13877 | PMID 32401418 Get It

AbstractThe present study investigated the impact of 12 weeks of pulsed electromagnetic field (PEMF) therapy on peripheral vascular function, blood pressure (BP), and nitric oxide in hypertensive individuals. Thirty hypertensive individuals (SBP > 130 mm Hg and/or MAP > 100 mm Hg) were assigned to either PEMF group (n = 15) or control group (n = 15). During pre‐assessment, participants underwent measures of flow‐mediated dilation (FMD), BP, and blood draw for nitric oxide (NO). Subsequently, they received PEMF therapy 3x/day for 12 weeks and, at conclusion, returned to the laboratory for post‐assessment. Fifteen participants from the PEMF group and 11 participants from the control group successfully completed the study protocol. After therapy, the PEMF group demonstrated significant improvements in FMD and FMDNOR (normalized to hyperemia), but the control group did not (P = .05 and P = .04, respectively). Moreover, SBP, DBP, and MAP were reduced, but the control group did not (P = .04, .04, and .03, respectively). There were no significant alterations in NO in both groups (P > .05). Twelve weeks of PEMF therapy may improve BP and vascular function in hypertensive individuals. Additional studies are needed to identify the mechanisms by which PEMF affects endothelial function.
Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia
Cha, Yong‐Mei , Li, Xuping , Yang, Mei , Han, Jie , Wu, Gang , Noseworthy, Peter A. , Mulpuru, Siva K. , Asirvatham, Samuel J. , Brady, Peter A. , Rho, Richard H., Friedman, Paul A. , Lee, Hon‐Chi, Tian, Ying , Zhou, Shenghua , Munger, Thomas M. , Ackerman, Michael J. , Shen, Win‐Kuang , Kapa, Suraj , Noseworthy, Peter A , Mulpuru, Siva K , Asirvatham, Samuel J , Friedman, Paul A , Zhou, Shenghua , Kapa, Suraj , McLeod, Christopher J. , Zhou, Shenghua

Mayo Clinic

Journal of Cardiovascular Electrophysiology | October 18, 2019 | Volume: 30 | Issue: 12 | Pages: 2920-2928

10.1111/jce.14233 | PMID 31625219 Get It

AbstractBackgroundInappropriate sinus tachycardia (IST) remains a clinical challenge because patients often are highly symptomatic and not responsive to medical therapy.ObjectiveTo study the safety and efficacy of stellate ganglion (SG) block and cardiac sympathetic denervation (CSD) in patients with IST.MethodsTwelve consecutive patients who had drug‐refractory IST (10 women) were studied. According to a prospectively initiated protocol, five patients underwent an electrophysiologic study before and after SG block (electrophysiology study group). The subsequent seven patients had ambulatory Holter monitoring before and after SG block (ambulatory group). All patients underwent SG block on the right side first, and then on the left side. Selected patients who had heart rate reduction ≥15 beats per minute (bpm) were recommended to consider CSD.ResultsThe mean (SD) baseline heart rate (HR) was 106 (21) bpm. The HR significantly decreased to 93 (20) bpm (P = .02) at 10 minutes after right SG block and remained significantly slower at 97(19) bpm at 60 minutes. Left SG block reduced HR from 99 (21) to 87(16) bpm (P = .02) at 60 minutes. SG block had no significant effect on blood pressure or HR response to isoproterenol or exercise (all P > .05). Five patients underwent right (n = 4) or bilateral (n = 1) CSD. The clinical outcomes were heterogeneous: one patient had complete and two had partial symptomatic relief, and two did not have improvement.ConclusionSG blockade modestly reduces resting HR but has no significant effect on HR during exercise. Permanent CSD may have a modest role in alleviating symptoms in selected patients with IST.
Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era
Amin, Mustapha, Kella, Danesh , Killu, Ammar M. , Padmanabhan, Deepak , Hodge, David O. , Golafshar, Michael A. , Chamberlain, Alanna M. , Lee, Justin Z. , Shen, Win‐Kuang , Friedman, Paul A. , Asirvatham, Samuel J. , Roger, Véronique L. , Mulpuru, Siva K. , Mulpuru, Siva K , Asirvatham, Samuel J , Kella, Danesh K , Chamberlain, Alanna M , Golafshar, Michael , Gersh, Bernard J.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | October 7, 2019 | Volume: 30 | Issue: 12 | Pages: 2869-2876

10.1111/jce.14218 | PMID 31588605 Get It

AbstractIntroductionMyocardial infarction (MI) is associated with an increase in subsequent heart failure (HF), recurrent ischemic events, sudden cardiac arrest, and ventricular arrhythmias (SCA‐VA). The primary objective of the study to determine the role of intercurrent HF and ischemic events on the development of SCA‐VA following first type I MI.Methods and resultsA retrospective cohort study of patients experiencing first type 1 MI in Olmsted County, Minnesota (2002‐2012) was conducted by identifying patients using the medical records linkage system (Rochester epidemiology project). Patients aged ≥18 years were followed from the time of MI till death or 31 July, 2017. Intercurrent HF and ischemic events were the primary exposures following MI and their association with outcome SCA‐VA was assessed. Eight hundred and sixty‐seven patients (mean age was 63 ± 14.5 years; 69% male; 49.8% ST‐elevation myocardial infarction) who had their first type I MI during the study period were included. Majority of acute MI patients were revascularized using percutaneous coronary intervention and bypass surgery (628 [72.43%] and 87 [10.03%] respectively). During a mean follow‐up of 7.69 ± 4.17 years, HF, recurrent ischemic events and SCA‐VA occurred in 155 (17.9%), 245 (28.3%), and 40 (4.61%) patients respectively. Low ejection fraction (adjusted hazard ratio [HR] 0.95; 95% confidence interval [CI], 0.93‐0.98; P < .001), intercurrent HF (adjusted HR 3.11; 95% CI, 1.39‐6.95; P = .006) and recurrent ischemic events (adjusted HR 3.47; 95% CI, 1.68‐7.18; P < .001) were associated with subsequent SCA‐VA.ConclusionSCA‐VA occurred in a small proportion of patients after MI and is associated with intercurrent HF and recurrent ischemic events.
The impact of pulsed electromagnetic field therapy on blood pressure and circulating nitric oxide levels: a double blind, randomized study in subjects with metabolic syndrome
Kim, Chul‐Ho , Wheatley, Courtney M. , Stewart, Glenn M. , Yeo, Dongwook , Shen, Win-Kuang, Johnson, Bruce D. , Wheatley-Guy, Courtney M

Mayo Clinic

Blood Pressure | August 9, 2019 | Volume: 29 | Issue: 1 | Pages: 47-54

10.1080/08037051.2019.1649591 | PMID 31394939 Get It

Achieving durable mitral isthmus block: Challenges, pitfalls, and methods of assessment
Hamoud, Naktal, Abrich, Victor A. , Shen, Win‐Kuang , Mulpuru, Siva K. , Hamoud, Naktal S, Srivathsan, Komandoor

Mayo Clinic

Journal of Cardiovascular Electrophysiology | July 23, 2019 | Volume: 30 | Issue: 9 | Pages: 1679-1687

10.1111/jce.14079 | PMID 31332867 Get It

AbstractBackground and objectivesMacroreentrant atrial tachycardias often occur following atrial fibrillation ablation, most commonly due to nontransmural lesions in prior ablation lines. Perimitral atrial flutter is one such arrhythmia which requires ablation of the mitral isthmus. Our objectives were to review the literature regarding ablation of the mitral isthmus and to provide our approach for assessment of mitral isthmus block.MethodsWe review anatomical considerations, ablation strategies, and assessment of conduction block across the mitral isthmus, which is subject to several pitfalls. Activation sequence and spatial differential pacing techniques are discussed for assessment of both endocardial and epicardial bidirectional mitral isthmus block.ResultsTraditional methods for verifying mitral isthmus block include spatial differential pacing, activation mapping, and identification of double potentials. Up to 70% of cases require additional ablation in the coronary sinus (CS) to achieve transmural block. Interpretation of transmural block is subject to six pitfalls involving pacing output, differentiation of endocardial left atrial recordings from epicardial CS recordings, identification of a slowly conducting gap in the line, and catheter positioning during spatial differential pacing. Interpretation of unipolar electrograms can identify nontransmural lesions. We employ a combined epicardial and endocardial assessment of mitral isthmus block, which involves using a CS catheter for epicardial recording and a duodecapolar Halo catheter positioned around the mitral annulus for endocardial recording.ConclusionsThe assessment of transmural mitral isthmus block can be challenging. Placement of an endocardial mapping catheter around the mitral annulus can provide a precise assessment of conduction across the mitral isthmus.
A Systematic Review of Noninvasive Electrocardiogram Monitoring Devices for the Evaluation of Suspected Cardiovascular Syncope
Trombetta, Lucia, Erba, Luca , Bozzano, Viviana , Barbic, Franca , Casazza, Giovanni , Dipaola, Franca , Furlan, Raffaello , Kenny, Rose Anne , Quinn, James , Sheldon, Robert S. , Shen, Win-Kuang, Sun, Benjamin , Thiruganasambandamoorthy, Venkatesh , Reed, Matthew J. , Solbiati, Monica , Sacco, Roberto M., Costantino, Giorgio , Raj, Satish R , Thiruganasambandamoorthy, Venkatesh , Kenny, Rose Anne , Dipaola, Franca , Furlan, Raffaello

Mayo Clinic

Journal of Medical Devices | February 8, 2019 | Volume: 13 | Issue: 2 | Pages: No page available

10.1115/1.4042795 Get It

The aims of this study were (1) to identify research publications studying noninvasive electrocardiogram (ECG) monitoring devices, (2) to define and categorize current technology in noninvasive ECG recording, and (3) to discuss desirable noninvasive recording features for personalized syncope evaluation to guide technological advancement and future studies. We performed a systematic review of the literature that assessed noninvasive ECG-monitoring devices, regardless of the reason for monitoring. We performed an Internet search and corresponded with syncope experts and companies to help identify further eligible products. We extracted information about included studies and device features. We found 173 relevant papers. The main reasons for ECG monitoring were atrial fibrillation (n = 45), coronary artery disease (n = 10), syncope (n = 8), palpitations (n = 8), other cardiac diseases (n = 67), and technological aspects of monitoring (n = 35). We identified 198 devices: 5 hospital telemetry devices, 12 patches, 46 event recorders, 70 Holter monitors, 23 external loop recorders, 20 mobile cardiac outpatient telemetries, and 22 multifunctional devices. The features of each device were very heterogeneous. There are a large number of ECG-monitoring devices with different features available in the market. Our findings may help clinicians select the appropriate device for their patients. Since there are only a few published articles analyzing their usefulness in syncope patients, further research might improve their use in this clinical setting.
Real‐world incidence of efficacy and safety outcomes in patients on direct oral anticoagulants with left ventricular systolic dysfunction at a tertiary referral center
Tseng, Andrew S. , Shen, Win‐Kuang , McBane, Robert D. , Mankad, Sunil , Esser, Heidi, Vucicevic, D., Shamoun, Fadi , Shamoun, Fadi E., Tseng, A S , McBane, Robert , Schleifer, J. William

Mayo Clinic

Clinical Cardiology | December 16, 2017 | Volume: 40 | Issue: 12 | Pages: 1328-1332

10.1002/clc.22833 | PMID 29247519 Get It

BackgroundPatients with heart failure (HF) have increased risk for thromboembolic events. Real‐world incidences of efficacy and safety outcomes of direct oral anticoagulants (DOACs) in patients with left ventricular systolic dysfunction (LVSD) are of growing clinical interest.HypothesisReal‐world efficacy and safety outcomes of DOACs in patients with LVSD will be similar to those of LVSD or HF subgroups in the RE‐LY, ROCKET‐AF, and ARISTOTLE trials.MethodsWe performed a retrospective review of adult patients with LVSD (left ventricular ejection fraction ≤40%) on DOAC therapy between 2010 and 2016. Incidences of safety and efficacy outcomes of anticoagulation with DOACs were extracted from primary and secondary hospital discharge diagnoses.ResultsDOACs were prescribed to 287 patients with LVSD over a mean follow‐up of 313.3 ± 52.3 days. Many patients had moderate and severe chronic kidney disease (28.9% and 10.1%, respectively) and indications for anticoagulation therapy other than atrial fibrillation (19.9%). For efficacy outcomes, the calculated incidence rates of ischemic stroke and systemic embolism were 1.2 (95% confidence interval [CI]: 0.25‐3.56) and 0.81 (95% CI: 0.10‐2.94) events per 100 person‐years, respectively. For the safety outcomes, incidence rates of GI bleeding and intracranial hemorrhage were 2.4 (95% CI: 0.8‐5.3) and 0.41 (95% CI: 0.1‐2.2) events per 100 patient‐years, respectively.ConclusionsOur findings are largely compatible with the results of LVSD or HF subgroups in RE‐LY, ROCKET‐AF, and ARISTOTLE trials and add to increasing confidence that DOACs can be safely used for stroke and systemic embolism prevention in patients with LVSD.
Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures
Lee, Justin Z. , Ling, Jayna, Diehl, Nancy N. , Hodge, David O. , Padmanabhan, Deepak , Killu, Ammar M. , Madhavan, Malini , Cha, Yong‐Mei , Deshmukh, Abhishek , Shen, Win-Kuang, Friedman, Paul A. , Munger, Thomas M. , Asirvatham, Samuel J. , Packer, Douglas L. , Mulpuru, Siva K. , Kapa, Suraj , Asirvatham, Samuel J , Noseworthy, Peter A. , McLeod, Christopher J. , Srivathsan, Komandoor , Kusumoto, Fred

Mayo Clinic

Circulation | October 18, 2017 | Volume: 137 | Issue: 1 | Pages: 24-33

10.1161/circulationaha.117.030523 | PMID 29046320 Get It

Background: Recognition of rates and causes of hard, patient-centered outcomes of death and cerebrovascular events (CVEs) after heart rhythm disorder management (HRDM) procedures is an essential step for the development of quality improvement programs in electrophysiology laboratories. Our primary aim was to assess and characterize death and CVEs (stroke or transient ischemic attack) after HRDM procedures over a 17-year period. Methods: We performed a retrospective cohort study of all patients undergoing HRDM procedures between January 2000 and November 2016 at the Mayo Clinic. Patients from all 3 tertiary academic centers (Rochester, Phoenix, and Jacksonville) were included in the study. All in-hospital deaths and CVEs after HRDM procedures were identified and were further characterized as directly or indirectly related to the HRDM procedure. Subgroup analysis of death and CVE rates was performed for ablation, device implantation, electrophysiology study, lead extraction, and defibrillation threshold testing procedures. Results: A total of 48 913 patients (age, 65.7±6.6 years; 64% male) who underwent a total of 62 065 HRDM procedures were included in the study. The overall mortality and CVE rates in the cohort were 0.36% (95% confidence interval [CI], 0.31–0.42) and 0.12% (95% CI, 0.09–0.16), respectively. Patients undergoing lead extraction had the highest overall mortality rate at 1.9% (95% CI, 1.34–2.61) and CVE rate at 0.62% (95% CI, 0.32–1.07). Among patients undergoing HRDM procedures, 48% of deaths directly related to the HDRM procedure were among patients undergoing device implantation procedures. Overall, cardiac tamponade was the most frequent direct cause of death (40%), and infection was the most common indirect cause of death (29%). The overall 30-day mortality rate was 0.76%, with the highest being in lead extraction procedures (3.08%), followed by device implantation procedures (0.94%). Conclusions: Half of the deaths directly related to an HRDM procedure were among the patients undergoing device implantation procedures, with cardiac tamponade being the most common cause of death. This highlights the importance of the development of protocols for the quick identification and management of cardiac tamponade even in procedures typically believed to be lower risk such as device implantation.
Response by Mulpuru and Shen to Letter Regarding Article, “Selective Modulation of the Cardiac Autonomic Nervous System: A New Strategy for Treatment of Cardioinhibitory Syncope”
Mulpuru, Siva K. , Shen, Win-Kuang

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | July 14, 2017 | Volume: 10 | Issue: 7 | Pages: No page available

10.1161/circep.117.005523 | PMID 28705879 Get It

Assessment and Treatment of Syncope
Shen, Win-Kuang, Sheldon, Robert S.

Mayo Clinic

JAMA Cardiology | June 14, 2017 | Volume: 2 | Issue: 8 | Pages: 920

10.1001/jamacardio.2017.1784 | PMID 28614562 Get It